Stephens Upgrades Exelixis (EXEL) Stock, Raises PT
Exelixis, Inc. (NASDAQ:EXEL) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds.
Posts Tagged ‘NASDAQ:EXEL’
10 Unstoppable Stocks to Buy According to Hedge Funds
As per Morgan Stanley, investors can see gains in equities and high-quality fixed income for 2025, despite a slowdown in global economic growth. In the Midyear Investment Outlook...
BofA Hikes Exelixis, Inc. (EXEL) Target Amid CRC Caution
On Thursday, analysts at BofA Securities raised the price target for Exelixis, Inc. (NASDAQ:EXEL) to $46 from $45, with a Neutral rating.
Exelixis, Inc. (NASDAQ:EXEL) Q1 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Exelixis First Quarter 2025 Financial Results Conference Call.
15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies
Even after his passing in 2024, billionaire investor and mathematician Jim Simons remains known as the "Quant King" of hedge funds due to the extraordinary success of Renaissance...
20 Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy
Uncertainty is around every corner of the U.S. stock market, affecting investors’ decisions.
7 Most Profitable Biotech Stocks To Buy Right Now
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
10 Best Immunology Stocks To Buy Now
Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.
Renaissance Technologies Portfolio: Top 10 Stock Picks
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its investment programs.
Exelixis, Inc. (NASDAQ:EXEL) Q4 2024 Earnings Call Transcript
Exelixis, Inc. (NASDAQ:EXEL) Q4 2024 Earnings Call Transcript February 11, 2025Exelixis, Inc. misses on earnings expectations.
What Makes Exelixis (EXEL) an Investment Bet?
Riverwater Partners, an investment management company, released its “Sustainable Value Strategy” Q4 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Performing Biotech Stocks in 2024
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
Exelixis, Inc. (NASDAQ:EXEL) Q3 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Exelixis Third Quarter 2024 Financial Results Conference Call.
10 Largest Biotech Hedge Funds and Their Top Stock Picks
The ability to successfully make money through investment requires deep thinking and analysis.
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Exelixis, Inc. (NASDAQ:EXEL) Q2 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Exelixis Second Quarter 2024 Financial Results Conference Call.
Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript
Exelixis, Inc. misses on earnings expectations. Reported EPS is $0.17 EPS, expectations were $0.28.
Insiders Are Dumping These 10 Healthcare Stocks
In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping...
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
10 Biotech Stocks with Huge Potential
In this article, we will take a look at the 10 biotech stocks with huge potential.
10 Mid-Cap Stocks with Insider Purchases
In this article, we will take a detailed look at the 10 Mid-Cap Stocks with Insider Purchases. For a quick overview of such stocks, read our article 5 Mid-Cap Stocks with Insider...
Exelixis, Inc. (NASDAQ:EXEL) Q4 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Exelixis Fourth Quarter and Fiscal Year 2023 Financial Results Conference Call.
11 Stocks Insiders and Billionaires Are Crazy About
In this article, we will take a detailed look at the 11 Stocks Insiders and Billionaires Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks Insiders...
Exelixis, Inc. (NASDAQ:EXEL) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Exelixis Third Quarter 2023 Financial Results Conference Call.
14 Best Cancer Stocks To Buy Now
In this article, we discuss 14 best cancer stocks to buy.
Exelixis, Inc. (NASDAQ:EXEL) Q2 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Exelixis Secod Quarter 2023 Financial Results Conference Call.
11 Best Healthcare Stocks Under $50
In this article, we will be taking a look at the 11 best healthcare stocks under $50.
Exelixis, Inc. (NASDAQ:EXEL) Q1 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Exelixis First Quarter 2023 Financial Results Conference Call.
12 Best Biotech Stocks To Buy Under $20
The biotechnology industry is one of the hottest sectors right now, particularly in the aftermath of the coronavirus pandemic since it was this industry that developed messenger...
Exelixis, Inc. (NASDAQ:EXEL) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Exelixis Fourth Quarter and Full Year 2022 Financial Results Conference Call.
12 Cheap Biotech Stocks To Buy
In this article, we will be taking a look at 12 cheap biotech stocks to buy.
5 Best Healthcare Stocks For the Long Term
AbCellera Biologics Inc. (NASDAQ:ABCL) is a Canadian biotech company. AbCellera Biologics Inc. (NASDAQ:ABCL) is operating in the human antibodies space.
11 Cheap Healthcare Stocks To Invest In
In this article, we discuss the 11 cheap healthcare stocks to invest in.
10 Stocks That Will Skyrocket
In this article, we will be taking a look at 10 stocks that will skyrocket.
Top 10 Gainers on Wednesday
Notable stocks from the tech and industrials sectors, including The Trade Desk, Inc. (NASDAQ:TTD), Unity Software Inc. (NYSE:U) and Plug Power Inc.
5 Stocks Under $30 to Buy Today According to Billionaire Steven Cohen
In this piece, we will look at the ten stocks under $30 to buy today according to billionaire Steven Cohen.
How Did Hedge Funds’ Exelixis, Inc. (EXEL) Bets Fare?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
5 Best Stocks Under $20 According to Jim Simons’ Fund
In this article, we discuss the 5 best stocks under $20 according to Jim Simons’ Renaissance Technologies.
Hedge Funds Are Selling Exelixis, Inc. (EXEL)
In this article you are going to find out whether hedge funds think Exelixis, Inc. (NASDAQ:EXEL) is a good investment right now.
Should I Buy Exelixis, Inc. (EXEL)?
At Insider Monkey, we pore over the filings of nearly 873 top investment firms every quarter, a process we have now completed for the latest reporting period.
Hedge Funds Are Buying Exelixis, Inc. (EXEL)
In this article we will check out the progression of hedge fund sentiment towards Exelixis, Inc. (NASDAQ:EXEL) and determine whether it is a good investment right now.
Is EXEL Stock A Buy or Sell?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
Is EXEL A Good Stock To Buy According To Hedge Funds?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Hedge Funds Have Never Been This Bullish On Exelixis, Inc. (EXEL)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Did Hedge Funds Make The Right Call On Exelixis, Inc. (EXEL) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Going Back and Forth About Exelixis, Inc. (EXEL)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Were These Hedge Funds Right About Selling Exelixis, Inc. (EXEL)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
